We are live on ! Find out more
IRMD icon

iRadimed
IRMD

35 hedge funds and large institutions have $12.9M invested in iRadimed in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.79% less ownership

Funds ownership: 16.75% → 13.97% (-2.8%)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

24% less funds holding

Funds holding: 46 → 35 (-11)

43% less capital inflows, than outflows

Capital inflows: $3.6M | Capital outflows: $6.29M

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
35
Holders Change
-11
Holders Change %
-23.91%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
14
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$2.93M
2
Element Capital Management
Element Capital Management
New York
+$170K
3
Paloma Partners
Paloma Partners
Connecticut
+$125K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$92.9K
5
AQR Capital Management
AQR Capital Management
Connecticut
+$76.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.46M
2
Municipal Employees' Retirement System of Michigan
Municipal Employees' Retirement System of Michigan
Michigan
-$1.03M
3
Globeflex Capital
Globeflex Capital
California
-$758K
4
State Street
State Street
Massachusetts
-$595K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$454K

IRMD Hedge Fund Activity: Q2 2017 in Review

35 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2017, worth a combined $12.9M — down 19% from $16M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IRMD and 6 opened new positions — a net loss of 11 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Ameriprise, opening a new position worth an estimated $2.93M. The largest seller was BlackRock, cutting an estimated $1.46M.

  • 35 institutional investors held iRadimed (IRMD) as of Q2 2017, down from 46 in Q1 2017.
  • Funds reported $12.9M of iRadimed stock for Q2 2017, down 19% quarter-over-quarter.
  • 6 funds opened new iRadimed positions in Q2 2017 and 17 closed out, a net change of -11 holders.
  • The largest iRadimed buyer in Q2 2017 was Ameriprise, an estimated $2.93M added.
  • The largest iRadimed seller in Q2 2017 was BlackRock, an estimated $1.46M sold.

Based on aggregated 13F filings for Q2 2017.